June 2013

About ISEH

The mission of ISEH is to promote the scientific knowledge and clinical application of basic hematology, immunology, stem cell research, cell and gene therapy, and all related aspects through research, publications, discussion, support of young investigators and organization of scientific meetings.

Table of Contents

Annual Meeting News
News from the Field
Member Profile
Society News
Don't Miss These Meetings
Experimental Hematology
Jobs
Members' Corner

Editor's Note: Carolina Abramovich, PhD

As time approaches, I hope to see you all at ISEH in Vienna. In the meantime, please send me any material or suggestions for the content of future newsletters to exphem@iseh.org.

Annual Meeting News

Join ISEH in Vienna, It’s All About the Science!

ISEH 42nd Annual Scientific Meeting
22-25 August, 2013
The Imperial Riding School Renaissance Hotel
Vienna, Austria

Meeting Quicklinks

This August, ISEH will meet in Vienna to share new and unpublished science with some of the leaders and rising stars of the industry. Don’t miss out, register today!

Sending five or more attendees from your facility? Take advantage of our group discount rates of $45USD or more per person. Learn more on how you can save on this exclusive scientific meeting.

Don’t forget – ISEH Members Save Money!

Did you know you could save up to $270 on your Annual Meeting registration by simply becoming a member? Join ISEH or renew your membership to save on your Annual Scientific Meeting Registration. See you in Vienna!

Feedback on future meeting dates requested

ISEH is now considering future meeting dates (2015 forward) and is interested in your preference on meeting timing.

The possible selections are:

· Late July
· Same time frame (End of August)
· Early August
· Early September
· Late September

Select one of the 5 options by clicking here.

News From the Field

News roundup: June 2013

A collection of industry, policy, government and other hot news from the field of hematology and stem cell.

Gamida Cell Reports StemEx® Phase II/III Study Safety and Efficacy Data

U of M Researchers Conduct World’s First Cord Blood Transplant Aimed at Curing Leukemia and HIV/AIDS


Pharmacyclics Completes Enrollment of First Phase III Ibrutinib CLL Study - RESONATE™ and Announces Completion of Enrollment of Phase II Ibrutinib MCL Study - SPARK

Stem Cells Boom in Vet Clinics

Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis

Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma

More Than 240 Innovative Medicines in Development for Leukemia, Lymphoma and Other Blood Cancers

SymBio Initiates Japanese Phase II Trial for TREAKISYM® (Bendamustine) in CLL

Onconova Completes Enrollment in ONTIME Pivotal Phase III Study of Rigosertib in Patients with High-Risk Myelodysplastic Syndromes

Member Profile

"He who dares wins" - Meet Achilles
Anagnostopoulos, MD

Dr. Achilles Anagnostopoulos is the Director and Head of the Hematology Department and Hematopoietic Cell Transplantation Unit at the G. Papanicolaou Hospital (GPH/HD-HCT), a tertiary referral center - the largest of its kind in Greece - with a capacity of 48 beds and a large outpatient clinic. It has a staff of 22 specialized hematologists, 16 residents in Hematology, 12 biologists, 15 laboratory technicians and 48 trained nurses. Read more on website

Society News

Membership benefits on the rise

Your membership benefits are growing; don’t keep your membership a secret!

As a member, you already know you receive discounted Annual Meeting registration, and that you receive online access to Experimental Hematology (not to mention fee-free submission for publication). But, did you know that the same organization that can help connect you with over 500 leaders in your industry is now offering FREE WEBINARS for members? The value of you ISEH membership will only continue to grow in the months to come.

Share the joys of IESH with a friend! Urge your friends and colleagues to renew online or join by credit card today by visiting the ISEH website. Renewing members can log on to their ISEH account with their username and password and select "Securely Renew Your Membership.” Anyone needing help logging in should contact ISEH Headquarters for assistance.

Inaugural webinar recap

June 4th 2013-"Combinatorial TranscriptionalControl of Blood Stem and Progenitor Cells"
Dr. Bertie Göttgensfrom the Cambridge Institute for Medical Research presented his group's research efforts into constructing hematopoietic transcriptional networks from single cell data. Read more on website

ISEH Finance Committee seeks investment volunteer

ISEH is undergoing an RFP process to find a financial investment partner. The ISEH Finance Committee is seeking an ISEH member to assist in conducting approximately 5 interviews of potential investment firms. Due to the geographic composition of the committee an individual within North America who is familiar with the United States financial system is needed. Read more on website

Don't Miss These Meetings

Noteworthy October sessions in Monaco, China

World Cord Blood Congress IV and Innovative Therapies for Sickle Cell Disease
24-27 October 2013 - Monaco, Principauté de Monaco

Stem Cells in Science and Medicine
14–17 October 2013 - Suzhou, China
Read more on website

Experimental Hematology

Experimental Hematology offers fast publication time

Experimental Hematology offers one of the fastest publication times in the field
Read more on website

Inside the May and June 2013 issues

Take a quick tour of the March and April issues and get a feel for the publication's cutting-edge scientific content. Read the full issues online.

In this Issue – May 2013

Migration of hematopoietic precursors during development and its clinical implications
Ciriza et al.

A step further toward the generation of a viable in-vitro stem cell niche
Deneault et al.

The hematopoietic role of the sodium-dependent phosphate import protein Sodium-Dependent Phosphate Import Protein, PiT1, is not associated with phosphate transport
Liu et al.

KI haplotype A: A novel predictive factor of complete molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
La Nasa etal.

In this Issue – June 2013


A mouse model of Hoxa9-mediated pre-T Lymphoblastic Leukemia

Beachy et al

Increased sensitivity of acute myeloid leukemia CD34+ cells to bortezomib by targeting NF-κB and MCL-1
Bosman et al.

Cytokine-induced killer cells as therapy against multiple myeloma
Liu et al.

Narrowing down the origin of endogenic mesoderm
Kataoka et al.

Regular and fast-track submissions are encouraged

The publishing team seeks manuscripts, reviews, perspectives and letters to the editor describing basic in vitro and in vivo research centered on normal and malignant hematopoiesis, as well as non-malignant hematologic diseases. Read more on website

Jobs

Editors Pick: New Career opportunities available

Group Leader in Stem Cell Biology (Paris, France)

Hematological Malignancies- BC/BE hematologist or medical oncologist (Hollywood, Florida)

Pediatric Hematology/ Oncology Faculty Position - Physician-Scientist (Columbus, Ohio)

Medical Director-Oncology (Cambridge, Massachusetts)

Research Scientist in Stem Cell Biology (Stanford, California)

Postdoctoral Fellow in Stem Cells and Cancer (Beijing, China)

Assistant Professor (Boston, Massachusetts)

Members' Corner

Kudos to Patricia Ernst

Congratulations to Patricia Ernst for the publication of her paper entitled:

"An MLL-dependent transcriptional network sustains hematopoiesis" in PNAS (Published online before print June 6, 2013, doi: 10.1073/pnas.1301278110)

Web Bug from http://c.ymcdn.com/email_image.asp?b71a9789d948b03f51ad98ae6df93590e412b1f04cca1320958165706d82054dbe3f080a